The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
EASL Recommendations on Treatment of Hepatitis C 2016
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., Romero-Gomez, M., Zarski, J.-P., Agarwal, K., Buggisch, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402454 · Cited by 1,705
Global distribution and prevalence of hepatitis C virus genotypes
Messina, J. P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G. S., Pybus, O. G., & Barnes, E. (2015) · Hepatology · doi:10.1002/hep.27259 · Cited by 1,589
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., Nahass, R., Ghalib, R., Gitlin, N., Herring, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316366 · Cited by 1,307
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., Lawitz, E., Lok, A. S., Hinestrosa, F., Thuluvath, P. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306218 · Cited by 1,190
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D. E., Lawitz, E., Shiffman, M. L., Schiff, E., Ghalib, R., Ryan, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402355 · Cited by 1,130
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N., Abergel, A., Mangia, A., Lai, C.-L., Chan, H. L. Y., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512610 · Cited by 1,106
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Feld, J. J., Kowdley, K. V., Coakley, E., Sigal, S., Nelson, D. R., Crawford, D., Weiland, O., Aguilar, H., Xiong, J., Pilot-Matias, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315722 · Cited by 903
Conti, F., Buonfiglioli, F., Scuteri, A., Crespi, C., Bolondi, L., Caraceni, P., Foschi, F. G., Lenzi, M., Mazzella, G., Verucchi, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.015 · Cited by 897
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Poordad, F., Hezode, C., Trinh, R., Kowdley, K. V., Zeuzem, S., Agarwal, K., Shiffman, M. L., Wedemeyer, H., Berg, T., Yoshida, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402869 · Cited by 874
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Foster, G. R., Afdhal, N., Roberts, S. K., Bräu, N., Gane, E. J., Pianko, S., Lawitz, E., Thompson, A., Shiffman, M. L., Cooper, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512612 · Cited by 846
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Curry, M. P., O’Leary, J. G., Bzowej, N., Muir, A. J., Korenblat, K. M., Fenkel, J. M., Reddy, K. R., Lawitz, E., Flamm, S. L., Schiano, T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512614 · Cited by 804
Charlton, M., Everson, G. T., Flamm, S. L., Kumar, P., Landis, C., Brown, R. S., Fried, M. W., Terrault, N. A., O'Leary, J. G., Vargas, H. E., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.010 · Cited by 802
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1053/jhep.2002.36810 · Cited by 727
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Ferenci, P., Bernstein, D., Lalezari, J., Cohen, D., Luo, Y., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Nyberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402338 · Cited by 693
Nelson, D. R., Cooper, J. N., Lalezari, J. P., Lawitz, E., Pockros, P. J., Gitlin, N., Freilich, B. F., Younes, Z. H., Harlan, W., Ghalib, R., et al. (2015) · Hepatology · doi:10.1002/hep.27726 · Cited by 689
Roth, D., Nelson, D. R., Bruchfeld, A., Liapakis, A., Silva, M., Monsour, H., Martin, P., Pol, S., Londoño, M.-C., Hassanein, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00349-9 · Cited by 671
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Pawlotsky, J.-M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.003 · Cited by 519
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Zeuzem, S., Jacobson, I. M., Baykal, T., Marinho, R. T., Poordad, F., Bourlière, M., Sulkowski, M. S., Wedemeyer, H., Tam, E., Desmond, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401561 · Cited by 517
Zeuzem, S., Ghalib, R., Reddy, K. R., Pockros, P. J., Ari, Z. B., Zhao, Y., Brown, D. D., Wan, S., DiNubile, M. J., Nguyen, B.-Y., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0785 · Cited by 516
Hepatitis C virus kinetics during and immediately after liver transplantation
Garcia-Retortillo, M., Forns, X., Feliu, A., Moitinho, E., Costa, J., Navasa, M., Rimola, A., & Rodes, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31773 · Cited by 503
Foster, G. R., Irving, W. L., Cheung, M. C. M., Walker, A. J., Hudson, B. E., Verma, S., McLauchlan, J., Mutimer, D. J., Brown, A., Gelson, W. T. H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.029 · Cited by 492
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Naggie, S., Cooper, C., Saag, M., Workowski, K., Ruane, P., Towner, W. J., Marks, K., Luetkemeyer, A., Baden, R. P., Sax, P. E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501315 · Cited by 470
Poordad, F., Schiff, E. R., Vierling, J. M., Landis, C., Fontana, R. J., Yang, R., McPhee, F., Hughes, E. A., Noviello, S., & Swenson, E. S. (2016) · Hepatology · doi:10.1002/hep.28446 · Cited by 460
Manns, M., Samuel, D., Gane, E. J., Mutimer, D., McCaughan, G., Buti, M., Prieto, M., Calleja, J. L., Peck-Radosavljevic, M., Müllhaupt, B., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00052-9 · Cited by 451
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
Sarrazin, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.011 · Cited by 423
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.045 · Cited by 419
Cheung, M. C. M., Walker, A. J., Hudson, B. E., Verma, S., McLauchlan, J., Mutimer, D. J., Brown, A., Gelson, W. T. H., MacDonald, D. C., Agarwal, K., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.019 · Cited by 408
Andreone, P., Colombo, M. G., Enejosa, J. V., Koksal, I., Ferenci, P., Maieron, A., Müllhaupt, B., Horsmans, Y., Weiland, O., Reesink, H. W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.045 · Cited by 365
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.035 · Cited by 361
Charlton, M., Gane, E. J., Manns, M. P., Brown, R. S., Curry, M. P., Kwo, P. Y., Fontana, R. J., Gilroy, R. K., Teperman, L. W., Muir, A. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.001 · Cited by 347
Belli, L. S., Berenguer, M., Cortesi, P. A., Strazzabosco, M., Rockenschaub, S.-R., Martini, S., Morelli, C., Donato, F., Volpes, R., Pageaux, G.-P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.010 · Cited by 343
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Neumann, U. P., Berg, T., Bahra, M., Seehofer, D., Langrehr, J. M., Neuhaus, R., Radke, C., & Neuhaus, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.029 · Cited by 339
Curry, M. P., Forns, X., Chung, R. T., Terrault, N. A., Brown, R., Fenkel, J. M., Gordon, F., O’Leary, J., Kuo, A., Schiano, T., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.023 · Cited by 334
Swain, M. G., Lai, M., Shiffman, M. L., Cooksley, W. G. E., Zeuzem, S., Dieterich, D. T., Abergel, A., Pessôa, M. G., Lin, A., Tietz, A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.009 · Cited by 328
Rockstroh, J. K., Nelson, M., Katlama, C., Lalezari, J., Mallolas, J., Bloch, M., Matthews, G. V., Saag, M. S., Zamor, P. J., Orkin, C., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00114-9 · Cited by 305
Saxena, V., Koraishy, F. M., Sise, M. E., Lim, J. K., Schmidt, M., Chung, R. T., Liapakis, A., Nelson, D. R., Fried, M. W., Terrault, N. A., et al. (2016) · Liver International · doi:10.1111/liv.13102 · Cited by 300
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Pockros, P. J., Reddy, K. R., Mantry, P. S., Cohen, E., Bennett, M., Sulkowski, M. S., Bernstein, D. E., Cohen, D. E., Shulman, N. S., Wang, D., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.078 · Cited by 278
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
Sise, M. E., Bloom, A. K., Wisocky, J., Lin, M. V., Gustafson, J. L., Lundquist, A. L., Steele, D., Thiim, M., Williams, W. W., Hashemi, N., et al. (2016) · Hepatology · doi:10.1002/hep.28297 · Cited by 261
Martin, N. K., Vickerman, P., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.029 · Cited by 230
Forns, X., Charlton, M., Denning, J., McHutchison, J. G., Symonds, W. T., Brainard, D., Brandt‐Sarif, T., Chang, P., Kivett, V., Castells, L., et al. (2015) · Hepatology · doi:10.1002/hep.27681 · Cited by 229
Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn237 · Cited by 222
Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations
Martin, N. K., Vickerman, P., Miners, A., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2012) · Hepatology · doi:10.1002/hep.24656 · Cited by 221
Terrault, N. A., Zeuzem, S., Di Bisceglie, A. M., Lim, J. K., Pockros, P. J., Frazier, L. M., Kuo, A., Lok, A. S., Shiffman, M. L., Ben Ari, Z., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.004 · Cited by 219
Castéra, L., Sebastiani, G., Le Bail, B., de Lédinghen, V., Couzigou, P., & Alberti, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.008 · Cited by 214
Patient-physician role relationships and patient activation among individuals with chronic illness
Alexander, J. A., Hearld, L. R., Mittler, J. N., & Harvey, J. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2011.01354.x · Cited by 206
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Grebely, J., Robaeys, G., Bruggmann, P., Aghemo, A., Backmund, M., Bruneau, J., Byrne, J., Dalgard, O., Feld, J. J., Hellard, M., et al. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.07.005 · Cited by 194
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., Hosaka, T., et al. (2013) · Hepatology · doi:10.1002/hep.26087 · Cited by 191
Freiman, J. M., Tran, T. M., Schumacher, S. G., White, L. F., Ongarello, S., Cohn, J., Easterbrook, P. J., Linas, B. P., & Denkinger, C. M. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0065 · Cited by 180
Martinot‐Peignoux, M., Stern, C., Maylin, S., Ripault, M., Boyer, N., Leclere, L., Castelnau, C., Giuily, N., El Ray, A., Cardoso, A., et al. (2010) · Hepatology · doi:10.1002/hep.23444 · Cited by 176
Sulkowski, M. S., Vargas, H. E., Di Bisceglie, A. M., Kuo, A., Reddy, K. R., Lim, J. K., Morelli, G., Darling, J. M., Feld, J. J., Brown, R. S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.10.013 · Cited by 176
Management of chronic viral hepatitis before and after renal transplantation
Gane, E., & Pilmore, H. (2002) · Transplantation · doi:10.1097/00007890-200208270-00001 · Cited by 175
Laboratory Diagnostics for Hepatitis C Virus Infection
Kamili, S., Drobeniuc, J., Araujo, A. C., & Hayden, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis368 · Cited by 173
Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study
Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., & Wright, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.023 · Cited by 162
Feld, J. J., Moreno, C., Trinh, R., Tam, E., Bourgeois, S., Horsmans, Y., Elkhashab, M., Bernstein, D. E., Younes, Z., Reindollar, R. W., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.005 · Cited by 160
Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C
Shivkumar, S., Peeling, R. W. W., Jafari, Y., Joseph, L., & Pai, N. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00006 · Cited by 152
Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antivirals
Chhatwal, J., Wang, X., Ayer, T., Kabiri, M., Chung, R. T., Hur, C., Donohue, J. M., Roberts, M. S., & Kanwal, F. (2016) · Hepatology · doi:10.1002/hep.28571 · Cited by 149
Dried Blood Spot for Hepatitis C Virus Serology and Molecular Testing
Tuaillon, É., Mondain, A., Meroueh, F., Ottomani, L., Picot, M., Nagot, N., de Perre, P. V., & Ducos, J. (2009) · Hepatology · doi:10.1002/hep.23407 · Cited by 142
Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution
Nault, J., & Colombo, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.004 · Cited by 127
Bruno, S., Marco, V. D., Iavarone, M. A., Roffi, L., Crosignani, A., Calvaruso, V., Aghemo, A., Cabibbo, G., Viganò, M., Boccaccio, V., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.034 · Cited by 123
Vermehren, J., Kau, A., Gärtner, B. C., Göbel, R., Zeuzem, S., & Sarrazin, C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00755-08 · Cited by 116
Khuroo, M. S., Khuroo, M. S., & Khuroo, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121450 · Cited by 92
Factors associated with spontaneous clearance of chronic hepatitis C virus infection
Bulteel, N., Sarathy, P. P., Forrest, E. H., Stanley, A. J., Innes, H. A., Mills, P. R., Valerio, H., Gunson, R. N., Aitken, C., Morris, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.030 · Cited by 91
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
Chevaliez, S., & Pawlotsky, J. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.11.004 · Cited by 89
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing
Cammà, C., Cabibbo, G., & Craxì, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.033 · Cited by 86
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Grebely, J., Knight, E., Ngai, T., Genoway, K. A., Raffa, J. D., Storms, M. M., Gallagher, L., Krajden, M., Dore, G. J., Duncan, F., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06238.x · Cited by 82
Interferon as treatment for acute hepatitis C
Cammà, C., Almasio, P. L., & Craxı̀, A. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088245 · Cited by 79
Darke, S. G., Kaye, S. S., & Duflou, J. A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01601.x · Cited by 77
Siu, L., Foont, J., & Wands, J. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214374 · Cited by 74
Currie, S. L., Ryan, J. C., Tracy, D., Wright, T. L., George, S., McQuaid, R., Kim, M., Shen, H., & Monto, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.011 · Cited by 63
Grebely, J., Raffa, J., Lai, C., Kerr, T., Fischer, B., Krajden, M., Dore, G., & Tyndall, M. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01279.x · Cited by 60
Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir
Renard, S., Borentain, P., Salaün, E., Benhaourech, S., Maille, B., Darque, A., Brégigeon, S., Colson, P., Laugier, D., Reynaud‐Gaubert, M., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.09.018 · Cited by 55
Bruggmann, P., Dampz, M., Gerlach, T., Kravecz, L., & Falcato, L. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.016 · Cited by 50
Virologic Tools for HCV Drug Resistance Testing
Fourati, S., & Pawlotsky, J. (2015) · Viruses · doi:10.3390/v7122941 · Cited by 49
Harris, R., Martin, N. K., Rand, E. A., Mandal, S., Mutimer, D., Vickerman, P. T., Ramsay, M. E., Angelis, D. D., Hickman, M., & Harris, H. (2016) · Journal of Viral Hepatitis · doi:10.1111/jvh.12529 · Cited by 47
Interferon for acute hepatitis C
Myers, R. P., Regimbeau, C., Thévenot, T., Leroy, V., Mathurin, P., Opolon, P., Zarski, J., & Poynard, T. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000369 · Cited by 45
Moon, C., Jung, K. S., Kim, D. Y., Baatarkhuu, O., Park, J. Y., Kim, B. K., Kim, S. U., Ahn, S. H., & Han, K. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3361-6 · Cited by 42
Kwo, P. Y., Gane, E. J., Peng, C., Pearlman, B. L., Vireling, J., Serfaty, L., Buti, M., Shafran, S. D., Stryszak, P., Lin, L.-W., et al. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)31088-6 · Cited by 39
Lan, C. L., Guillygomarc’h, A., Danielou, H., Dréau, G. L., Lainé, F., Vedeilhie, C., Deugnier, Y., Brissot, P., Guyader, D., & Moirand, R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.021 · Cited by 35
Rodis, J. L., & Kibbe, P. J. (2010) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3181f443cb · Cited by 31
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Smolders, E. J., de Kanter, C. T. M. M., de Knegt, R. J., van der Valk, M., Drenth, J. P. H., & Burger, D. M. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0407-2 · Cited by 31
D’Ambrosio, R., Aghemo, A., Rossetti, V., Carrinola, R., & Colombo, M. G. (2016) · Liver International · doi:10.1111/liv.13203 · Cited by 22
Deterding, K., Spinner, C. D., Schott, E., Welzel, T. M., Gerken, G., Klinker, H., Spengler, U., Wiegand, J., Wiesch, J. S. Z., Pathil, A., et al. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)00177-x · Cited by 13
Asselah, T., Hézode, C., Qaqish, R. B., Elkhashab, M., Hassanein, T., Papatheodoridis, G., Feld, J. J., Alqahtani, S. A., Pilot-Matias, T., Yu, Y., et al. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)01618-4 · Cited by 11
Cited by
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Carrat, F., Fontaine, H., Dorival, C., Simony, M., Diallo, A., Hezode, C., De Ledinghen, V., Larrey, D., Haour, G., Bronowicki, J.-P., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32111-1 · Cited by 628
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
Lentine, K. L., Kasiske, B. L., Levey, A. S., Adams, P. L., Alberú, J., Bakr, M. A., Gallon, L., Garvey, C. A., Guleria, S., Li, P. K.-T., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001769 · Cited by 582
Metadata
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 66
- Issue
- 1
- Pages
- 153-194
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4211243282
- Cited by
- 985
- References
- 104
- FWCI
- 146.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.